Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Cases. May 16, 2014; 2(5): 160-166
Published online May 16, 2014. doi: 10.12998/wjcc.v2.i5.160
Published online May 16, 2014. doi: 10.12998/wjcc.v2.i5.160
Table 1 Laboratory results from a patient with essential mixed cryoglobulinemic syndrome
| Laboratory investigation | Test results (reference ranges) |
| Complete blood cell counts | |
| Hemoglobin | 8.5 g/dL (11.5-15.4 g/dL) |
| White blood cell count | 15200 × 109/L (4.0-11.0 × 109/L) |
| Neutrophils | 87% (40%-80%) |
| Lymphocytes | 10% (20%-40%) |
| Platelets | 23000/L (150-400 × 109/L) |
| Coagulation profile | |
| APTT | 28 s (25.8 s) |
| INR | 1.98 (< 1.35) |
| Renal functions | |
| Urea | 88 mg/dL (15-39 mg/dL) |
| Creatinine | 6.2 mg/dL (0.5-1.5 mg/dL) |
| Liver functions | |
| Total bilirubin | 6.1 mg/dL (0.2-1.0 mg/dL) |
| Direct bilirubin | 3.2 mg/dL (0-0.25 mg/dL) |
| Alkaline phosphatase | 202 U/mL (32-92 U/mL) |
| Alanine amino transferase | 10 U/mL (10-40 U/mL) |
| Gamma glutamyl transferase | 204 U/mL (7-64 U/mL) |
| Bone chemistry | |
| Calcium | 7.5 mg/dL (8.4-10.2 mg/dL) |
| Phosphorus | 4.4 mg/dL (2.5-4.0 mg/dL) |
| Albumin | 2.2 mg/dL (3.5-5.0 mg/dL) |
| Urine detailed report | Anuric on admission, later showed +2 proteinuria; no red blood cells, no cast |
| Immunological work-up | |
| Complement 3 | 0.4 g/L (0.79-1.52 g/L) |
| Complement 4 | 0.01 g/L (0.16-0.38 g/L) |
| Anti-nuclear antibodies | Negative |
| ANCA | Negative |
| Rheumatoid factor activity | Positive: 859 IU/mL (cut off < 20 IU/mL) |
| Anti-cyclic citrullinated peptide | Negative |
| Anti-extractable nuclear antigens | Weakly positive for anti-Ro52 |
| C-reactive protein | 0.1 mg/dL (cut-off < 0.7 mg/dL) |
| Viral markers | |
| HBsAg | Negative |
| Anti-HCV | Negative |
| Anti-HIV | Negative |
| HCV RNA | Not detected |
- Citation: Anis S, Abbas K, Mubarak M, Ahmed E, Bhatti S, Muzaffar R. Vasculitis with renal involvement in essential mixed cryoglobulinemia: Case report and mini-review. World J Clin Cases 2014; 2(5): 160-166
- URL: https://www.wjgnet.com/2307-8960/full/v2/i5/160.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v2.i5.160
